All data are based on the daily closing price as of August 12, 2025
t
Towa Pharmaceutical
4553.TSE
19.87 USD
-0.08
-0.40%
Overview
Last close
19.87 usd
Market cap
977.97M usd
52 week high
23.11 usd
52 week low
16.24 usd
Target price
27.63 usd
Valuation
P/E
7.6913
Forward P/E
16.7785
Price/Sales
0.5569
Price/Book Value
0.8396
Enterprise Value
2.22B usd
EV/Revenue
1.2711
EV/EBITDA
6.8666
Key financials
Revenue TTM
1.77B usd
Gross Profit TTM
640.62M usd
EBITDA TTM
292.41M usd
Earnings per Share
2.6 usd
Dividend
0.47 usd
Total assets
3.16B usd
Net debt
1.24B usd
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.